1. Home
  2. SGBX vs ARTL Comparison

SGBX vs ARTL Comparison

Compare SGBX & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGBX
  • ARTL
  • Stock Information
  • Founded
  • SGBX 2007
  • ARTL 2011
  • Country
  • SGBX United States
  • ARTL United States
  • Employees
  • SGBX N/A
  • ARTL N/A
  • Industry
  • SGBX RETAIL: Building Materials
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGBX Consumer Discretionary
  • ARTL Health Care
  • Exchange
  • SGBX Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • SGBX 4.2M
  • ARTL 3.6M
  • IPO Year
  • SGBX 2017
  • ARTL N/A
  • Fundamental
  • Price
  • SGBX $0.53
  • ARTL $0.95
  • Analyst Decision
  • SGBX
  • ARTL Strong Buy
  • Analyst Count
  • SGBX 0
  • ARTL 2
  • Target Price
  • SGBX N/A
  • ARTL $5.50
  • AVG Volume (30 Days)
  • SGBX 773.2K
  • ARTL 28.2K
  • Earning Date
  • SGBX 04-14-2025
  • ARTL 03-03-2025
  • Dividend Yield
  • SGBX N/A
  • ARTL N/A
  • EPS Growth
  • SGBX N/A
  • ARTL N/A
  • EPS
  • SGBX N/A
  • ARTL N/A
  • Revenue
  • SGBX $5,889,321.00
  • ARTL N/A
  • Revenue This Year
  • SGBX $273.79
  • ARTL N/A
  • Revenue Next Year
  • SGBX $39.31
  • ARTL N/A
  • P/E Ratio
  • SGBX N/A
  • ARTL N/A
  • Revenue Growth
  • SGBX N/A
  • ARTL N/A
  • 52 Week Low
  • SGBX $0.38
  • ARTL $0.91
  • 52 Week High
  • SGBX $9.30
  • ARTL $1.70
  • Technical
  • Relative Strength Index (RSI)
  • SGBX 39.30
  • ARTL 30.99
  • Support Level
  • SGBX $0.46
  • ARTL $0.97
  • Resistance Level
  • SGBX $0.68
  • ARTL $1.01
  • Average True Range (ATR)
  • SGBX 0.07
  • ARTL 0.05
  • MACD
  • SGBX -0.01
  • ARTL -0.02
  • Stochastic Oscillator
  • SGBX 16.81
  • ARTL 1.77

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

Share on Social Networks: